On Tuesday, the Shanghai and Shenzhen stock markets showed a shock adjustment pattern, and the three major stock indexes rebounded slightly at the opening and fell back after shock. As of the close, the Shanghai Composite Index closed at 320394 points, down 0.33%; The Shenzhen Component Index fell 0.46%, and the gem index fell slightly by 0.06%.
Co19-vid is active again. Some market participants believe that with the recent gradual realization of the performance of companies related to the epidemic prevention concept, its capital logic is being transformed into fundamental logic to a certain extent, thus driving the expected warming of the whole sector.
In terms of specific stocks, Hangzhou Alltest Biotech Co.Ltd(688606) gained 20% limit on Tuesday, and several stocks such as Hangzhou Biotest Biotech Co.Ltd(688767) , Wuhan Easy Diagnosis Biomedicine Co.Ltd(002932) , Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) followed.
On the news, on March 28, Hangzhou Alltest Biotech Co.Ltd(688606) released the announcement of pre increase of performance in the first quarter of 2022. The company said that according to the preliminary calculation of the financial department, it is expected to realize a net profit of 1.03 billion yuan to 1.19 billion yuan in the first quarter of 2022, with a year-on-year increase of 585.40% to 691.87%.
Hangzhou Alltest Biotech Co.Ltd(688606) said that during the reporting period, the epidemic situation outside China was still repeated, the company continued to be committed to covid-19 epidemic prevention and control, and covid-19 detection business orders continued to grow steadily, resulting in a significant increase in the company’s performance in the first quarter of 2022 compared with the same period last year.
China International Capital Corporation Limited(601995) said that the concept of covid-19 prevention and control is still a hot spot in the recent market. In the window period disclosed in the annual report and the first quarterly report, the market will still take high performance growth as the main investment line. It is suggested to continue to pay attention to covid-19 testing, covid-19 therapeutic drugs and other related topics, and gradually select and distribute excellent companies with international innovation ability and consumption upgrading potential while taking into account valuation and fundamentals.
In terms of decline, the real estate sector with strong performance on Monday made a correction yesterday and Yango Group Co.Ltd(000671) fell by the limit. A number of consumer electronics concept stocks fell sharply during the session, of which Goertek Inc(002241) hit the limit and closed down 7.76%. The current market value of the company still exceeds 100 billion yuan. Another electronic leader with a market value of more than 200 billion yuan Luxshare Precision Industry Co.Ltd(002475) also closed down by more than 6%.
In terms of capital, northbound capital sold a small net 328 million yuan on Tuesday Wuliangye Yibin Co.Ltd(000858) , S.F.Holding Co.Ltd(002352) , Wuxi Apptec Co.Ltd(603259) were sold for 339 million yuan, 134 million yuan and 90 million yuan respectively Contemporary Amperex Technology Co.Limited(300750) net purchase took the lead, with an amount of 1.15 billion yuan.
Looking forward to the future, the China International Capital Corporation Limited(601995) strategy team said that the short-term market may still be repeated, but the more targeted “steady growth” policy may also gradually bring about the improvement of fundamental expectations. Similar to the sharp decline in the previous period, the short-term market may still be at the bottom stage. In combination with the recent market adjusted valuation, which has gradually approached the “bottom” level in December 2018 and March 2020, China International Capital Corporation Limited(601995) believes that from the medium-term perspective, market opportunities outweigh risks.
